Results 211 to 220 of about 49,327 (299)
Impact of the drip-and-ship model on the treatment of acute ischemic stroke in relation to distance from the thrombectomy center. [PDF]
Lieschke F +5 more
europepmc +1 more source
Company Websites: A New Measure of Disclosure
Abstract We propose a new measure of firms' disclosure based on company websites, which are widely available and contain a wealth of information. For a sample of U.S. public firms, we construct our disclosure measure using historical website data, validate it by correlating it with extant measures of disclosure and information asymmetry, and explore ...
ROMAIN BOULLAND +2 more
wiley +1 more source
Enhancing diagnostic precision for rare diseases using case-based reasoning. [PDF]
Noll R +5 more
europepmc +1 more source
Listen Closely: Measuring Vocal Tone in Corporate Disclosures
ABSTRACT We examine the usefulness of machine learning approaches for measuring vocal tone in corporate disclosures. We document a substantial mismatch between the widely adopted actor‐based training data underlying these approaches and speech in corporate disclosures.
Jonas Ewertz +3 more
wiley +1 more source
DNP-Enhanced Magic Angle Spinning Solid-State NMR Spectroscopy to Determine RNA-Ligand Interactions. [PDF]
Sudakov A +8 more
europepmc +1 more source
ABSTRACT Background In Ewing sarcoma (EwS), metastases, including those to bone marrow (BM), are the main factors influencing prognosis. Although reverse transcription polymerase chain reaction (RT‐PCR) offers greater sensitivity, the current EWING protocol defines BM metastases solely using light microscopic detection.
Thanh Pham +13 more
wiley +1 more source
Jawbone Cavitations: Current Understanding and Conceptual Introduction of Covered Socket Residuum (CSR). [PDF]
Ghanaati S +5 more
europepmc +1 more source
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is a curative option for secondary acute myeloid leukemia (sAML). This study compared haploidentical donor (Haplo), matched sibling donor (MSD), and matched unrelated donor (MUD) HSCT in patients with sAML in first complete remission (CR1).
Arnon Nagler +20 more
wiley +1 more source

